Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Lymphoma, Large B-Cell, Diffuse 36Multiple Myeloma 34Burkitt Lymphoma 33Lymphoma 31Leukemia, Myeloid, Acute 30Lymphoma, Non-Hodgkin 29Recurrence 26Breast Neoplasms 26Lymphoma, B-Cell 24Neoplasms 22Lymphoma, Follicular 22Leukemia, Lymphocytic, Chronic, B-Cell 22Myelodysplastic Syndromes 21Hodgkin Disease 18Triple Negative Breast Neoplasms 16Ovarian Neoplasms 16Leukemia 16Hematologic Neoplasms 15Melanoma 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Neuroblastoma 13Lymphoma, Mantle-Cell 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Pancreatic Neoplasms 11Leukemia, Biphenotypic, Acute 11Lymphoma, B-Cell, Marginal Zone 10Sarcoma 9Neoplasm Metastasis 9Leukemia, Myelomonocytic, Chronic 9

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chromosome 7, monosomy × Cyclophosphamide × 90 days × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡